<DOC>
	<DOCNO>NCT00668707</DOCNO>
	<brief_summary>There evidence support use melatonin , natural health product , additional treatment aid cancer patient . This study design see daily ingestion 20 milligram melatonin one year lower incidence develop lung cancer recurrence and/or death . Only patient diagnosis non small cell lung cancer eligible surgical resection participate trial . The study also assess change quality life , pain , fatigue , anxiety , sleep , depression amongst participant .</brief_summary>
	<brief_title>Adjuvant Melatonin Prevention Lung Cancer Recurrence Mortality</brief_title>
	<detailed_description>The trial employ two-armed parallel placebo control trial design whereby patient diagnosis non small cell lung cancer randomize receive either 20 mg melatonin nightly identically match placebo . All patient follow two year primary outcome assess two year time point secondary outcomes evaluate throughout course trial .</detailed_description>
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<mesh_term>Recurrence</mesh_term>
	<mesh_term>Melatonin</mesh_term>
	<criteria>Clinical diagnosis non small cell lung cancer Eligible surgical resection Willingness adhere randomize treatment Availability followup schedule visit Taking exogenous melatonin</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>melatonin</keyword>
	<keyword>natural health product ( NHP )</keyword>
	<keyword>lung cancer</keyword>
	<keyword>complementary alternative medicine ( CAM )</keyword>
	<keyword>randomize clinical trial</keyword>
</DOC>